( Johns Hopkins University Bloomberg School of Public Health ) Between 2000 and 2008, the proportion of HIV-infected patients in the US receiving effective treatment known as highly active antiretroviral therapy increased, and HIV-infected patients appeared to be less infectious and have healthier immune systems at death.
